Grufity logo
Grufity logo

Latest Iron Triangle Partners LP Stock Portfolio

$874Million | No. of Holdings #27

Iron Triangle Partners LP Performance

2025 Q4+6.97%
YTD+15.61%
2024+9.42%

About Iron Triangle Partners LP and 13F Hedge Fund Stock Holdings

On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, Iron Triangle Partners LP reported an equity portfolio of $874.7 Millions as of 31 Dec, 2025. <br><br> The top stock holdings of Iron Triangle Partners LP are CRL, ISRG, RGEN. The fund has invested 8.7% of it's portfolio in CHARLES RIV LABS INTL INC and 6.1% of portfolio in INTUITIVE SURGICAL INC. <br><br> The fund managers got completely rid off DEXCOM INC (DXCM), ABBVIE INC (ABBV) and MEDTRONIC PLC (MDT) stocks. They significantly reduced their stock positions in CVS HEALTH CORP (CVS), ELI LILLY & CO (LLY) and BRIGHTSPRING HEALTH SVCS INC. Iron Triangle Partners LP opened new stock positions in INTUITIVE SURGICAL INC (ISRG), BOSTON SCIENTIFIC CORP (BSX) and WATERS CORP (WAT). The fund showed a lot of confidence in some stocks as they added substantially to DOXIMITY INC (DOCS), VERACYTE INC (VCYT) and JAZZ PHARMACEUTICALS PLC (JAZZ).
Iron Triangle Partners LP Equity Portfolio Value
Last Reported on: 17 Feb, 2026
$874Million
  as of Feb 17, 2026

Iron Triangle Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Iron Triangle Partners LP made a return of 6.97% in the last quarter. In trailing 12 months, it's portfolio return was 15.61%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
intuitive surgical inc53,497,800
boston scientific corp40,120,700
waters corp39,945,600
bruker corp37,423,200
vertex pharmaceuticals inc34,867,900
fortrea hldgs inc34,264,200
merit med sys inc33,992,100
bio-techne corp27,488,300
New stocks bought by Iron Triangle Partners LP

Additions

Ticker% Inc.
doximity inc226
veracyte inc102
jazz pharmaceuticals plc94.78
ideaya biosciences inc73.14
charles riv labs intl inc41.69
adapthealth corp35.59
brookdale sr living inc23.02
repligen corp18.69
Additions to existing portfolio by Iron Triangle Partners LP

Reductions

Ticker% Reduced
cvs health corp-45.8
eli lilly & co-29.28
brightspring health svcs inc-27.54
Iron Triangle Partners LP reduced stake in above stock

Sold off

Ticker$ Sold
amicus therapeutics inc-15,533,500
adaptive biotechnologies cor-27,240,900
dexcom inc-57,196,500
exact sciences corp-27,355,000
medtronic plc-43,176,800
guardant health inc-24,992,000
glaukos corp-27,955,700
abbvie inc-46,383,500
Iron Triangle Partners LP got rid off the above stocks

Sector Distribution

Iron Triangle Partners LP has about 88.8% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare88.8
Others11.2

Market Cap. Distribution

Iron Triangle Partners LP has about 38.4% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • LARGE-CAP
  • UNALLOCATED
  • MEGA-CAP
  • SMALL-CAP
Category%
MID-CAP44.5
LARGE-CAP31.4
UNALLOCATED11.2
MEGA-CAP7
SMALL-CAP6.1

Stocks belong to which Index?

About 65.2% of the stocks held by Iron Triangle Partners LP either belong to S&P 500 or RUSSELL 2000 index.

  • S&P 500
  • Others
  • RUSSELL 2000
Index%
S&P 50044.4
Others34.7
RUSSELL 200020.8
Top 5 Winners (%)%
LLY
eli lilly & co
34.9 %
BKD
brookdale sr living inc
24.2 %
brightspring health svcs inc
23.0 %
CRL
charles riv labs intl inc
22.5 %
JAZZ
jazz pharmaceuticals plc
20.5 %
Top 5 Winners ($)$
CRL
charles riv labs intl inc
13.9 M
LLY
eli lilly & co
13.2 M
RGEN
repligen corp
8.9 M
JAZZ
jazz pharmaceuticals plc
8.4 M
brightspring health svcs inc
8.4 M
Top 5 Losers (%)%
DOCS
doximity inc
-29.9 %
Top 5 Losers ($)$
DOCS
doximity inc
-12.9 M

Iron Triangle Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Iron Triangle Partners LP

Iron Triangle Partners LP has 27 stocks in it's portfolio. About 53.2% of the portfolio is in top 10 stocks. DOCS proved to be the most loss making stock for the portfolio. CRL was the most profitable stock for Iron Triangle Partners LP last quarter.

$874.68MTotal Value
41.00Positions
17 Feb, 2026Last Reported
Current holdings of Current Stock Holdings of Iron Triangle Partners LP, last reported on 17 Feb, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ARGX
Argenx Se

Argenx Se

ARGX
Iron Triangle Partners LP's holding in Argenx Se over time
0%0.00
$0.00
0%
decreased 100 percentsold off